Portugal’s Infarmed Faces EU Law Clash Over CBD-Infused Cosmetics

THE WHAT? Portugal’s National Authority for Medicines and Health Products (Infarmed) has ordered the removal of multiple CBD-based cosmetic products from the market. The agency’s decision hinges on the claim that CBD from cannabis extracts is classified as a narcotic in Portugal, conflicting with the European Union’s principle of free movement of goods.

THE DETAILS 

• Infarmed mandated the withdrawal of CBD-infused products from brands including SVR, Naturasor, and Dermacol.
• The regulator’s position directly contradicts the European Court of Justice’s 2020 ruling that CBD is not a narcotic under international conventions.
• By blocking these products, Portugal risks violating EU law, which forbids member states from restricting legally produced CBD merchandise without scientific evidence of harm.
• The enforcement disrupts the growing local market for CBD skin care and may push manufacturers toward reformulation or synthetic alternatives to circumvent regulations.

THE WHY? With consumer demand for CBD-based personal care products on the rise across Europe, Portugal’s stance creates business uncertainty and potential legal challenges. Infarmed’s enforcement sets a precedent that diverges from more CBD-friendly regulatory approaches elsewhere in the EU, potentially deterring investment and innovation in the country’s cosmetics sector.

The post Portugal’s Infarmed Faces EU Law Clash Over CBD-Infused Cosmetics appeared first on Global Cosmetics News.